Medinice S.A. (ICE.WA) Stock Analysis & Winston Score
Medinice S.A. is a Polish medical technology company that develops devices for diagnosing heart and lung conditions. Its core products include portable electrocardiography (ECG) systems and respiratory diagnostic tools, aimed at hospitals, clinics, and individual patients. The company operates in the growing market for point-of-care diagnostics, where patients can be tested outside of traditional hospital settings. Medinice earns revenue primarily through hardware sales and, increasingly, through software and data services connected to its diagnostic devices. It is based in Poland and focuses mainly on European markets, though it is a small company still in an early commercial stage. The main risk the business faces is scaling up sales fast enough to reach profitability, as its current operating margins are negative and it competes against much larger, well-established medical device makers with greater resources and distribution networks.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (0/30)
- Growth: Mixed (7/20)
- Cash Flow: Data not available (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 74.20 PLN
Market Cap: 689M PLN
Sector: Healthcare
Industry: Medical - Devices
Exchange: Warsaw Stock Exchange


